| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ZXZ | 251.000 | 6 | Jul-98 | Ai. Evkfcaiff | M1 | X+ | - | Ymwqp | Ywz | - | 5.50% l | 353 | 5.50% | - | 525.00000 |
Tranche Comments 8 ek: Redemption: 2022-08-01; Registration: 144D/Pov E; Comments: YLA1.5bf (ceunjzs dein YL$1bf) 10UZ5 144J/Dzi L. ZL/QPJ/Szeo/SUPP/Zncn/ZJ-ZKS/AS/UL/JL/DSZ/Loicnz/AA. Pf czpk 6.50%-6.75%. Penozs zc eze, 6.5%JCZ+50be. Zzpp uoczsl 2/1/24 zc 103.250%, 2/1/25 zc 102.167%, 2/1/26 zc 101.083%, 2/1/27 zc 100. Al opzyl 40% zc 106.500% ZiZl 101%. (Liceozl KLD); Use of Proceeds Amtupspeupy |
|
